PB
MRVI icon

Pinnacle Bancorp’s Maravai LifeSciences MRVI Stock Holding History

Pinnacle Bancorp’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-474
Closed -$1.36K – 904
2025
Q3 		$1.36K Hold
474
– – ﹤0.01% 893
2025
Q2 		$1.14K Hold
474
– – ﹤0.01% 889
2025
Q1 		$1.05K Hold
474
– – ﹤0.01% 879
2024
Q4 		$2.58K Hold
474
– – ﹤0.01% 841
2024
Q3 		$3.94K Hold
474
– – ﹤0.01% 811
2024
Q2 		$3.39K Hold
474
– – ﹤0.01% 789
2024
Q1 		$4.11K Hold
474
– – ﹤0.01% 753
2023
Q4 		$3.1K Hold
474
– – ﹤0.01% 750
2023
Q3 		$4.74K Hold
474
– – ﹤0.01% 695
2023
Q2 		$5.89K Hold
474
– – ﹤0.01% 659
2023
Q1 		$6.64K Buy
+474
New +$6.81K ﹤0.01% 675

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinnacle Bancorp's MRVI Position: Q4 2025 in Review

Pinnacle Bancorp sold out of Maravai LifeSciences (MRVI) in Q4 2025, closing a stake of 474 shares — an estimated $1.36K sold.

Pinnacle Bancorp first reported a position in MRVI in Q1 2023 and held it in 11 quarters. The position peaked at $6.64K in Q1 2023. 159 funds tracked by Wall St. Rank hold MRVI as of Q4 2025.

  • Pinnacle Bancorp reported no remaining Maravai LifeSciences position as of Q4 2025 after selling out during the quarter.
  • Pinnacle Bancorp sold 474 Maravai LifeSciences shares in Q4 2025, an estimated $1.36K.
  • Pinnacle Bancorp first reported a position in Maravai LifeSciences in Q1 2023 and held it in 11 quarters.
  • Pinnacle Bancorp's Maravai LifeSciences position peaked at $6.64K in Q1 2023.
  • 159 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2025.

Based on Pinnacle Bancorp's 13F filing for Q4 2025, filed 22 Jan 2026.